GENETICALLY ENGINEERED VRL-LOADED ENDOTHELIAL CELLS EXPRESSING FGFR1/TRAIL/APO-2L CAUSED APOPTOTIC-INDUCED DRUG DELIVERY (AIDD) LEADING TO BYSTANDER KILLING EFFECT IN CHEMORESISTANT OVARIAN CARCINOMA CHARACTERISED BY OVER- EXPRESSION OF MDR-1 AND BCL-2